Synapse - Bonnie Reichman

Results (81)

Intraperitoneal therapy in the management of ovarian carcinoma

Conference Paper

Markman, M.; Hakes, T.; Reichman, B.; Hoskins, W.; Rubin, S.; Jones, W.; Almadones, L.; Lewis, J. L. Jr
Yale Journal of Biology and Medicine, Inc. (1989)

Fulltext@MSK | Save

Combination intraperitoneal (IP) chemotherapy of refractory/recurrent ovarian carcinoma (ROC) employing a regimen of cisplatin (C) and etoposide (E): A phase 2 trial

Meeting Abstract

Markman, M.; Reichman, B.; Hakes, T.; Rubin, S.; Hoskins, W.; Lewis, J. L.
Clinical Research (1988)

Fulltext@MSK | Save

High dose intravenous (IV) cisplatin (C) with sodium thiosulfate (STS) renal protection

Meeting Abstract

Markman, M.; Iannotti, N.; D'Acquisto, R.; Hakes, T.; Bajorin, D.; Kris, M.; Bosl, G.; Casper, E.; Reichman, B.; Magill, G.
Clinical Research (1988)

Fulltext@MSK | Save

Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancer

Journal Article

Reichman, B.; Markman, M.; Hakes, T.; Kemeny, N.; Kelsen, D.; Hoskins, W.; Rubin, S.; Lewis, J. L. Jr
Journal of Clinical Oncology (1988)

Fulltext@MSK | Save

Implementation of the group sequential methodology in a randomized trial in metastatic colorectal carcinoma

Journal Article

Kemeny, N.; Reichman, B.; Geller, N.; Hollander, P.
American Journal of Clinical Oncology (1988)

Fulltext@MSK | Save

Recurrence in bone (B) versus recurrence at other sites (non-B) following adjuvant cyclophosphamide, methotrexate and fluorouracil (CMF) chemotherapy (CT) for stage II and stage III breast cancer

Meeting Abstract

Cooper, K.; Scher, H. I.; Geller, N. L.; Chan, E. Y. W.; Reichman, B.; Hakes, T. B.
Proceedings of the American Association for Cancer Research Annual Meeting (1987)

Fulltext@MSK | Save

Phase I trial of N-phosphonacetyl-L-aspartate (PALA), methotrexate (MTX), 5-fluorouracil (FU), and leucovorin (LV) in advanced colorectal cancer (CRC)

Meeting Abstract

Kemeny, N.; Reichman, B.; Gordon, C.; Ellison, S.; Deonarine, S.; Slavik, B.; Martin, D.; Young, C.
Proceedings of the American Association for Cancer Research Annual Meeting (1987)

Fulltext@MSK | Save

Combination intravenous (IV) and intraperitoneal (IP) 5-fluorouracil (5-FU) therapy of malignant disease principally confined to the peritoneal cavity (PC)